Draft Evidence Review

Breast Cancer: Medication Use to Reduce Risk

January 15, 2019

Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services.

Expand All
Panel 1

Medication Use for the Risk Reduction of Primary Breast Cancer in Women: A Systematic Review for the U.S. Preventive Services Task Force (PDF File, 3.8 MB; PDF Help)